Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies.

Autor: Liefwalker DF; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, 97201, USA. liefwalk@ohsu.edu.; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97201, USA. liefwalk@ohsu.edu.; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA. liefwalk@ohsu.edu., Ryan M; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA., Wang Z; Department of Molecular & Cellular Endocrinology, Diabetes and Metabolism Research Institute, City of Hope Medical Center, Duarte, CA, 91010, USA., Pathak KV; Collaborative Center for Translational Mass Spectrometry, Translational Genomics Research Institute, 445 N 5th St, Phoenix, AZ, 85004, USA., Plaisier S; Collaborative Center for Translational Mass Spectrometry, Translational Genomics Research Institute, 445 N 5th St, Phoenix, AZ, 85004, USA., Shah V; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, 97201, USA.; Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, Portland, OR, 97201, USA., Babra B; Molecular & Cellular Biology, Oregon State University, Corvallis, Oregon, 97331, USA., Dewson GS; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, 97201, USA.; Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, Portland, OR, 97201, USA., Lai IK; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA., Mosley AR; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA., Fueger PT; Department of Molecular & Cellular Endocrinology, Diabetes and Metabolism Research Institute, City of Hope Medical Center, Duarte, CA, 91010, USA.; Comprehensive Cancer Center, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, 91010, USA., Casey SC; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA., Jiang L; Department of Molecular & Cellular Endocrinology, Diabetes and Metabolism Research Institute, City of Hope Medical Center, Duarte, CA, 91010, USA.; Comprehensive Cancer Center, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, 91010, USA., Pirrotte P; Collaborative Center for Translational Mass Spectrometry, Translational Genomics Research Institute, 445 N 5th St, Phoenix, AZ, 85004, USA., Swaminathan S; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Systems Biology, Beckman Research Institute of the City of Hope, Monrovia, CA, 91016, USA.; Department of Hematological Malignancies, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA., Sears RC; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, 97201, USA.; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97201, USA.; Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, Portland, OR, 97201, USA.

Publikováno v: Cancer & metabolism [Cancer Metab] 2021 Aug 16; Vol. 9 (1), pp. 31. Date of Electronic Publication: 2021 Aug 16.

Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression.

Autor: Hebb JPO; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. JonathanP.Hebb@nshealth.ca.; Division of Hematology, QEII Health Sciences Centre, Dalhousie University, Rm 422, Bethune Building, 1276 South Park Street, Halifax, NS, B3H 2Y9, Canada. JonathanP.Hebb@nshealth.ca., Mosley AR; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Vences-Catalán F; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Rajasekaran N; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Chemistry and Biochemistry, Northern Arizona University, Flagstaff, AZ, USA., Rosén A; Alligator Bioscience, Medicon Village, 223 81, Lund, Sweden., Ellmark P; Alligator Bioscience, Medicon Village, 223 81, Lund, Sweden.; Department of Immunotechnology, Lund University, Medicon Village, 223 81, Lund, Sweden., Felsher DW; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. DFelsher@Stanford.edu.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. DFelsher@Stanford.edu.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2018 Jan; Vol. 67 (1), pp. 47-60. Date of Electronic Publication: 2017 Sep 13.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.